☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
sk biopharmaceuticals
SK Biopharmaceuticals Teams Up with Full-Life Technologies to Develop FL-091 for Multiple Solid Tumors
July 17, 2024
SK Biopharmaceuticals Entered into a License Agreement with Eurofarma to Develop and Commercialize Cenobamate for Epilepsy in Lati...
July 15, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.